Results 221 to 230 of about 1,026,952 (386)

BETA-ADRE NERGIC BLOCKADE WITH PRONETHALOL DURING ANAESTHESIA

, 1964
Michael Johnstone
openalex   +1 more source

Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba. [PDF]

, 1968
Thierry Grandjean, J.-L. Rivier
openalex   +1 more source

NEUROMUSCULAR BLOCKADE

British Journal of Anaesthesia, 1982
openaire   +2 more sources

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

The effect of androgen blockade on [⁶⁸Ga]Ga-PSMA-11 and [¹⁸F]FDG PET uptake in patients with recurrent or metastatic salivary duct carcinoma: a prospective imaging study. [PDF]

EJNMMI Res
van Ruitenbeek NJ, Uijen MJM, Driessen CML, van Rijk MC, Peters SMB, Privé BM, Verhaegh GW, van Engen-van Grunsven ACH, Gotthardt M, Nagarajah J, van Herpen CML.   +10 more
europepmc   +1 more source

Effects of Beta-Receptor Blockade on the Systemic and Coronary Hemodynamic Response to an Increasing Ventricular Rate in the Unanesthetized Dog [PDF]

, 1969
Fred Cobb, Robert J. Bache, Paul A. Ebert, Judith C. Rembert, Joseph C. Greenfield   +4 more
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Neoadjuvant PD-1 blockade induces the autophagy of immune cells: a new target for synergistic therapy of recurrent glioblastoma. [PDF]

Biochem Biophys Rep
Xuan Z, Wang K, Zhu Q, Sun T, Jiang J, Wu Z, Zheng S, Zhao H.   +7 more
europepmc   +1 more source

Vascular responses after alpha adrenergic receptor blockade [PDF]

, 1968
François M. Abboud, John W. Eckstein
openalex   +1 more source

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

Nature Network Boston, 2020
D. Braun, Yue Hou, Z. Bakouny, M. Ficial, Miriam Sant’ Angelo, J. Forman, P. Ross-Macdonald, Ashton C. Berger, O. Jegede, L. Elagina, J. Steinharter, Maxine Sun, M. Wind-Rotolo, Jean-Christophe Pignon, A. Cherniack, Lee T Lichtenstein, D. Neuberg, P. Catalano, G. Freeman, A. Sharpe, D. McDermott, E. V. Van Allen, S. Signoretti, Catherine J. Wu, S. Shukla, T. Choueiri   +25 more
semanticscholar   +1 more source